Press release
Uterine Fibroid Treatment Market is expected to exhibit CAGR of 9.30% to hit a worth of USD 10.83 Billion by year 2032 end | PMR
๐๐ข๐ญ๐ก ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐๐ง๐ง๐ฎ๐๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐๐ญ๐ (๐๐๐๐) ๐จ๐ ๐.๐๐%, ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฎ๐ญ๐๐ซ๐ข๐ง๐ ๐๐ข๐๐ซ๐จ๐ข๐ ๐ญ๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ฌ ๐๐ฑ๐ฉ๐๐๐ญ๐๐ ๐ญ๐จ ๐ซ๐๐๐๐ก ๐ ๐ฏ๐๐ฅ๐ฎ๐ ๐จ๐ ๐จ๐ฏ๐๐ซ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐ ๐๐ซ๐จ๐ฆ ๐๐ง ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐.Many people with uterine fibroids have nil indicators, or they have lightly irritating manifestations that they can cope with. They are not cancer. They seldom encroach on pregnancy. They frequently escalate and tend to reduce after menopause when the extent of reproductive hormones plummet. Medicines such as Gonadotropin-releasing hormone (GnRH) agonists cure fibroids by obstructing the body from rendering hormones estrogen and progesterone. This places the person in an interim menopause state. Therefore, menstrual periods halt, fibroids diminish, and anemia frequently improves.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/uterine-fibroid-treatment-market/request-for-sample
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐ ๐๐๐ญ๐จ๐ซ๐ฌ
โข The uterine fibroid treatment industry has seen notable advancements in the cure of uterine fibroids with the consent of two oral GnRH antagonists Yselty & Myfembree. Yselty was confirmed by the EMA in June 2022 to cure average to serious indicators of uterine leiomyomas, while Myfembree was confirmed by the US Food and Drug Administration for the cure of massive bleeding linked with uterine fibroids. These medicinal therapies are fuelling the market growth,
โข There is an escalating significance in the growing consciousness of uterine fibroids and training people about conditions. These involve endeavors by firms such as Minerva Surgical, which instigated a uterine fitness education website in November 2021.
๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐จ๐ฏ๐๐ซ๐๐
Significant market contenders are financing massively in research and development to expand their product lines, which will permit the market to grow even more. Some of the companies which are currently dominating the market are:
โข Myovant Sciences
โข Pfizer
โข Abbvie
โข Ferring
โข AstraZeneca
โข Bayer
โข Amring Pharmaceuticals
โข Watson Pharma
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ: https://www.polarismarketresearch.com/buy/2512/2
๐๐ญ๐๐ซ๐ข๐ง๐ ๐ ๐ข๐๐ซ๐จ๐ข๐๐ฌ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข GnRH antagonists' segment is anticipated to witness faster growth owing to its high efficacy and effective treatment option.
โข Sub-mucosal fibroids segment accounted for the larger market share. This is primarily due its high prevalence rate and severity. It is most common among Asian women
โข Retail pharmacies segment expected to garner substantial share, owing to easy availability of drugs and other combination therapies
โข North America is expected to grow larger revenue, owing to high prevalence rate in the US. presence of better medical facilities, and awareness among individuals about ill effects.
๐๐๐จ๐ ๐ซ๐๐ฉ๐ก๐ข๐๐๐ฅ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐
The regions covered in the report are Europe, North America, Asia Pacific, Middle East & Africa, and Latin America. Also, according to the study, in 2022, North America held the largest uterine fibroid treatment market share. The growing existence of well-established healthcare frameworks escalated consciousness levels among the population, and commending compensation policies are also pushing growth in the region. Moreover, the escalating consciousness about the obtainability of contemporary treatment alternatives and the growing acquisition of minimally invasive surgeries are also anticipated to push the
๐ฆ๐๐ซ๐ค๐๐ญ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐ญ๐ก๐ ๐ซ๐๐ ๐ข๐จ๐ง.
โข North America (U.S., Canada)
โข Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
โข Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
โข Latin America (Brazil, Mexico, Argentina)
โข Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐: https://www.polarismarketresearch.com/industry-analysis/uterine-fibroid-treatment-market
๐๐๐ซ๐ค๐๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง
โข ๐ฝ๐ฎ ๐ฟ๐ง๐ช๐ ๐๐ฎ๐ฅ๐
o Subserosal Fibroids
o Intramural Fibroids
o Submucosal Fibroids
o Pedunculated Fibroids
โข ๐ฝ๐ฎ ๐ฟ๐ง๐ช๐ ๐พ๐ก๐๐จ๐จ
o Gonadotropin-releasing Hormone (GnRH) Agonists
o Gonadotropin-releasing Hormone (GnRH) Antagonists
o Progestin-releasing Intrauterine Device (IUD) & Contraceptives
o Non-hormonal Medications
o Others
โข ๐ฝ๐ฎ ๐๐ฃ๐ ๐๐จ๐
o Hospital Pharmacies
o Retail Pharmacies
o Others
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐๐๐ข๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐๐ญ๐๐ข๐ฅ๐ฌ : https://www.polarismarketresearch.com/industry-analysis/uterine-fibroid-treatment-market
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
๐๐ก๐ฉ๐ง๐๐จ๐ค๐ช๐ฃ๐ ๐๐๐๐๐ก๐ ๐๐ช๐๐๐๐จ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/ultrasound-needle-guides-market
๐๐๐ฉ๐๐ซ๐๐ง๐จ๐ ๐๐ฃ ๐๐๐๐ก๐ฉ๐๐๐๐ง๐ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/metaverse-in-healthcare-market
๐ฟ๐๐๐๐๐ฉ๐๐ ๐๐๐ฉ๐๐ฃ๐ค๐ฅ๐๐ฉ๐๐ฎ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/diabetic-retinopathy-market
๐๐๐ฃ๐๐ก๐ ๐๐จ๐ ๐ผ๐จ๐จ๐๐ข๐๐ก๐๐๐จ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/single-use-assemblies-market
๐ฝ๐ก๐๐๐๐๐ฃ๐ ๐ฟ๐๐จ๐ค๐ง๐๐๐ง๐จ ๐๐๐ง๐ ๐๐ฉ : https://www.polarismarketresearch.com/industry-analysis/bleeding-disorders-market
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uterine Fibroid Treatment Market is expected to exhibit CAGR of 9.30% to hit a worth of USD 10.83 Billion by year 2032 end | PMR here
News-ID: 3479924 • Views: โฆ
More Releases from Polaris Market Research & Consulting

Dialysis Catheters Market to Reach USD 1.34 Billion by 2034, Growing at a 4.8% C โฆ
๐๐ก๐ ๐๐ข๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐๐ญ๐ก๐๐ญ๐๐ซ๐ฌ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฌ๐ข๐ณ๐ ๐ฐ๐๐ฌ ๐ฏ๐๐ฅ๐ฎ๐๐ ๐๐ญ ๐๐๐ ๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐. ๐๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐๐๐ญ๐๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐จ ๐๐๐ ๐,๐๐๐.๐๐ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐๐ฑ๐ก๐ข๐๐ข๐ญ๐ข๐ง๐ ๐ ๐๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐๐ง๐ง๐ฎ๐๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐๐ญ๐ ๐จ๐ ๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง
Dialysis catheters are transcutaneous conduits utilized to acquire entrance to the intravascular or intraperitoneal spaces as a medium for kidney substitution therapy. Catheters can be categorized into extracorporeal dialysis catheters or peritoneal dialysis catheters.โฆ

Viscosupplementation Market to Reach USD 15.26 Billion by 2034, Growing at a 10. โฆ
๐๐ข๐ฌ๐๐จ๐ฌ๐ฎ๐ฉ๐ฉ๐ฅ๐๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ข๐ณ๐ ๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฏ๐ข๐ฌ๐๐จ๐ฌ๐ฎ๐ฉ๐ฉ๐ฅ๐๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฐ๐จ๐ซ๐ญ๐ก ๐๐๐ ๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ง๐ ๐ญ๐จ ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐% ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide viscosupplementation industry. Comprehensive analyses of sales volume, price, revenue, market share, and important companies are included. Theโฆ

Green Technology and Sustainability Market Size to Surge to US$ 121.05 Billion A โฆ
๐๐ซ๐๐๐ง ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐๐ฎ๐ฌ๐ญ๐๐ข๐ง๐๐๐ข๐ฅ๐ข๐ญ๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐ข๐ณ๐ ๐๐๐ฏ๐๐ง๐ฎ๐, ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ, ๐๐ง๐ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ ๐ซ๐๐๐ง ๐ญ๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐๐ง๐ ๐ฌ๐ฎ๐ฌ๐ญ๐๐ข๐ง๐๐๐ข๐ฅ๐ข๐ญ๐ฒ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฐ๐๐ฌ ๐๐ฌ๐ญ๐ข๐ฆ๐๐ญ๐๐ ๐ญ๐จ ๐๐ ๐ฐ๐จ๐ซ๐ญ๐ก ๐๐๐ ๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐๐๐๐ ๐๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐๐๐ข๐๐ญ๐๐ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐ง๐ ๐ญ๐จ ๐๐๐ ๐๐๐.๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐ฒ ๐๐๐๐, ๐ฐ๐ข๐ญ๐ก ๐ ๐๐๐๐ ๐จ๐ ๐๐.๐%, ๐๐ซ๐จ๐ฆ ๐๐๐๐ ๐ญ๐จ ๐๐๐๐.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐จ๐ฉ๐:
This comprehensive study provides an accurate overview of the worldwide green technology and sustainability industry. Comprehensive analyses of sales volume, price,โฆ

Advanced Energy Storage Systems Market Set for Growth: Expected to Reach USD 46. โฆ
๐๐๐ฏ๐๐ง๐๐๐ ๐๐ง๐๐ซ๐ ๐ฒ ๐๐ญ๐จ๐ซ๐๐ ๐ ๐๐ฒ๐ฌ๐ญ๐๐ฆ๐ฌ ๐๐๐ซ๐ค๐๐ญ
The advanced energy storage systems market size was valued at USD 18.44 billion in 2024. It is projected to grow to USD 46.31 billion by 2034, exhibiting a compound annual growth rate of 9.7% from 2025 to 2034.
๐๐๐ซ๐ค๐๐ญ ๐๐๐๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:
Advanced energy storage is usually a battery that utilizes a smart energy management system to charge and discharge as required. Usually, AES is positioned as a culmination load-shavingโฆ
More Releases for Fibroid
Uterine Fibroid Treatment Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Uterine Fibroid Treatment market analysis, which studies the Uterine Fibroid Treatment's industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global โUterine Fibroid Treatment Market 2020-2025โ Research Report categorizes the global Uterine Fibroid Treatment market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key playersโฆ
Uterine fibroid treatment Market: Regional markets, technology, types, and appli โฆ
Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%โ40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroidโฆ
Uterine fibroid treatment Market | Key Trends and Forecast Research Report 2023
Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%โ40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroidโฆ
United States Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title United States Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalDataโs new report, "United States Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the United States Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeveโฆ
Spain Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Spain Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalDataโs new report, "Spain Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the Spain Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures andโฆ
Germany Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023
ReportsWorldwide has announced the addition of a new report title Germany Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023 to its growing collection of premium market research reports.
GlobalDataโs new report, "Germany Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023", provides key procedures data on the Germany Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures andโฆ